Epidermal stem cell properties in mice with altered polyamines

多胺改变的小鼠表皮干细胞特性

• 批准号: 7879457
• 负责人: LISA M SHANTZ
• 金额: $ 7.76万
• 依托单位: PENNSYLVANIA STATE UNIV HERSHEY MED CTR
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-07-01 至 2011-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7879457
• 关键词: Address; Anabolism; Back; Binding; Biological Models; Bromodeoxyuridine; CD34 gene; Carcinogens; Cell Cycle Regulation; Cell Proliferation; Cell Separation; Cells; Chemopreventive Agent; Chronic; Cyclin D1; DL-alpha-Difluoromethylornithine; Development; Differentiation Antigens; Down-Regulation; Enzymes; Epidermis; Event; Exposure to; Future; Genes; Ha-ras Oncogene; Hair follicle structure; Human; Hyperplasia; In Vitro; Integrins; Keratin; Label; Lead; MEKs; Malignant Neoplasms; Measures; Modeling; Molecular; Monitor; Mus; Mutation; Nude Mice; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitor; Pathway interactions; Phenotype; Polyamines; Population; Prevention; Property; Proteins; Public Health; Role; Signal Transduction Pathway; Skin; Skin Cancer; Skin Carcinogenesis; Skin Carcinoma; Skin Neoplasms; Skin Transplantation; Skin graft; Small Interfering RNA; Sorting - Cell Movement; Stem cells; Stratum Basale; Study models; Techniques; Tissues; Transgenes; Transgenic Mice; Transgenic Organisms; Tumor Promotion; Tumor Suppressor Proteins; Undifferentiated; Up-Regulation; Wild Type Mouse; Work; base; cell growth; cell type; in vivo; in vivo Model; inhibitor/antagonist; interest; keratin 5; keratinocyte; keratinocyte differentiation; knock-down; mouse model; novel; overexpression; promoter; research study; response; self-renewal; skin cancer prevention; stem; three-dimensional modeling; transgene expression; tumor; tumorigenesis

DESCRIPTION (provided by applicant): Although it is known that the mammalian epidermis is maintained by self-renewal of stem cells, the underlying mechanisms, and the changes that occur in skin cancer, are not well-defined. A more thorough understanding of stem cell proliferation and differentiation will provide potential targets for skin cancer prevention. One of the most widely used models for the study of skin carcinogenesis is the mouse model of initiation and promotion. The initiating event occurs when exposure to a carcinogen induces genetic changes in epidermal stem cells, which are thought to be located in the bulge region of the hair follicle. Initiation causes activation of the Ha-ras oncogene and chronic up-regulation of the Raf/MEK/ERK pathway. Our previous work demonstrates that the polyamine metabolizing enzyme ornithine decarboxylase (ODC) is downstream of MEK, and induction of ODC activity is necessary for skin tumor development. We have also shown that antizyme (AZ), which binds to ODC and targets it for degradation, is a potent tumor suppressor in skin carcinogenesis. The central hypothesis of the proposed work is that the tumor suppressor effects of AZ are associated with decreased proliferation of epidermal stem cells and induction of keratinocyte differentiation. The proposed experiments use mice with expression of AZ in the skin, along with either MEK or cyclin D1 (CD1), which like ODC is a downstream target of MEK. Expression of each transgene is driven by either the Keratin 5 or Keratin 14 promoter, thus directing expression primarily to the hair follicle bulge and modifying important signal transduction pathways in the population of cells crucial to stem cell expansion, keratinocyte differentiation and tumorigenesis. Preliminary studies with mice expressing both AZ and CD1 have led to the hypothesis that reduced ODC activity resulting from targeted AZ expression restricts cell growth in epidermal stem cells and inhibits tumorigenesis at least in part by suppressing CD1 activity. Aim 1 will measure stem cell expansion in bulge cells of MEK, MEK/AZ, CD1 and CD1/AZ mice using BrdU labeling and expression of a6-integrin and CD34, both markers of epidermal stem cells. We will directly address whether CD1 is controlled by ODC in bulge cells by isolating these cells from several transgenic lines using FACS sorting and monitoring CD1 expression. Aim 2 will use organotypic raft cultures of human keratinocytes expressing MEK, CD1 and/or AZ. This three-dimensional model system will allow us to address changes in tissue organization and expression of differentiation markers in response to transgene expression. The possibility that AZ is acting independently of ODC will be addressed by comparing results in AZ-expressing cells to those in cells expressing siRNA targeted to the ODC protein, thus knocking down ODC without changing AZ expression. To extend these studies to an in vivo model, human keratinocytes expressing our genes of interest will be grafted onto athymic mice, and changes in epidermal proliferation and differentiation will be measured. Information obtained from the proposed work will lead to future studies that address the broader question of what pathways are altered in follicular stem cells upon ODC downregulation.

描述（由申请人提供）： 虽然已知哺乳动物表皮是通过干细胞的自我更新来维持的，但皮肤癌中发生的潜在机制和变化并没有很好地定义。对干细胞增殖和分化的深入了解将为皮肤癌的预防提供潜在的靶点。用于研究皮肤癌发生的最广泛使用的模型之一是启动和促进的小鼠模型。当暴露于致癌物诱导表皮干细胞发生遗传变化时，就会发生起始事件，表皮干细胞被认为位于毛囊的隆起区域。起始引起Ha-ras癌基因的活化和Raf/MEK/ERK途径的慢性上调。我们以前的工作表明，多胺代谢酶鸟氨酸脱羧酶（ODC）是下游的MEK，和ODC活性的诱导是必要的皮肤肿瘤的发展。我们还表明，抗酶（AZ），结合到ODC和目标降解，是一个有效的肿瘤抑制剂在皮肤癌的发生。这项工作的中心假设是AZ的肿瘤抑制作用与表皮干细胞增殖减少和角质形成细胞分化诱导有关。拟议的实验使用皮肤中表达AZ的小鼠，沿着MEK或细胞周期蛋白D1（CD 1），其与ODC一样是MEK的下游靶点。每种转基因的表达由角蛋白5或角蛋白14启动子驱动，因此主要将表达引导至毛囊隆突并修饰对干细胞扩增、角质形成细胞分化和肿瘤发生至关重要的细胞群中的重要信号转导途径。对同时表达AZ和CD 1的小鼠进行的初步研究已得出以下假设：靶向AZ表达导致的ODC活性降低限制了表皮干细胞中的细胞生长，并至少部分通过抑制CD 1活性来抑制肿瘤发生。目的1将使用BrdU标记和α 6-整联蛋白和CD 34（表皮干细胞的两种标志物）的表达来测量MEK、MEK/AZ、CD 1和CD 1/AZ小鼠的隆突细胞中的干细胞扩增。我们将通过使用FACS分选和监测CD 1表达从几个转基因系中分离这些细胞，直接解决CD 1是否由隆突细胞中的ODC控制。目的2将使用表达MEK、CD 1和/或AZ的人角质形成细胞的器官型筏培养物。这种三维模型系统将使我们能够解决组织组织结构和分化标记物表达的变化，以响应转基因表达。AZ独立于ODC起作用的可能性将通过比较AZ表达细胞与表达靶向ODC蛋白的siRNA的细胞中的结果来解决，从而敲低ODC而不改变AZ表达。为了将这些研究扩展到体内模型，将表达我们感兴趣的基因的人角质形成细胞移植到无胸腺小鼠上，并测量表皮增殖和分化的变化。从拟议的工作中获得的信息将导致未来的研究，解决更广泛的问题，即在卵泡干细胞中ODC下调后哪些途径发生了改变。